Janus Henderson Group Plc【JHG】株式ニュース | ADVFN

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NYSE
Janus Henderson Group Plc (JHG)
Janus Henderson Group Plc (JHG) ニュース

Janus Henderson Group Plc (JHG)

42.99

-0.56

(-1.29%)

終了 1月23日 6:00AM

42.99

0.00

(0.00%)

取引時間後: 6:04AM

個人投資家向けのプロ仕様のツール。

プレミアム

Form S-4/A - Registration of securities, business combinations: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 3 - Initial statement of beneficial ownership of securities

Janus Henderson to Report Fourth Quarter and Full-Year 2024 Results

Janus Henderson Group plc (NYSE: JHG) will announce its fourth quarter and full-year 2024 results on Friday, January 31, 2025, at 7:30 a.m. ET. A...

Form S-4/A - Registration of securities, business combinations: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Janus Henderson to Present at the Goldman Sachs Financial Services Conference

Janus Henderson Group plc (NYSE: JHG; the “Company”) announced today that Ali Dibadj, CEO, is scheduled to speak at the Goldman Sachs Financial...

Form S-4 - Registration of securities, business combinations

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

boarddork

boarddork 5分前

That’s a lot of push pins and zig zag strings to make that ultimate conclusion.

weedtrader420

weedtrader420 6分前

BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET

janice shell

janice shell 6分前

She's one of the very few who actually deserves a pardon.

Hoskuld

Hoskuld 7分前

This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.

StayHumble

StayHumble 8分前

wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!

WALL STREET KID

WALL STREET KID 8分前

$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6

vinmantoo

vinmantoo 11分前

Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.

WhAtEvA1

WhAtEvA1 12分前

With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.

glens0

glens0 12分前

$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M

Zorch305

Zorch305 13分前

theorysuit

theorysuit 14分前

You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO

WHITTENHALLJR

WHITTENHALLJR 15分前

Yes I bet it 2x better then before strap in stock-nuts

Bourbon_on_my_cornflakes

Bourbon_on_my_cornflakes 15分前

Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days. Anavex’s shares gained 63.3% over the last three months compared with the S&P 500’s adva

GUNSMOKE

GUNSMOKE 15分前

https://www.otcmarkets.com/filing/html?id=18121280&guid=sJ0-kqxrs0Hhh3h

band aid

band aid 16分前

Bobby, he or she is saying that this is a PIG. I wish you good luck here and I hope you hit it out of the park. As for me I took a huge pounding on this trash but still hold a small position just in case the sky falls out of the universe and this PIG could figure out a way to sell some of their jun

glens0

glens0 17分前

CTOR Not to many shares left in the market. Should go up real fast when good news comes out.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M

NoMoDo

NoMoDo 17分前

Done. He is an amazing boy. Nuclear engineer.

Acme Investments

Acme Investments 17分前

👇 When he comes through it will be something else for you clowns to talk about!! Sitting around counting days is Sad!!

Whalatane

Whalatane 18分前

Recent Open Market purchases by the Chairman of the Board ...David Mott
On December 19, 2024, Mott purchased 213,300 shares at an average price of $4.6722, for a total amount of $996,58034.
On November 13, 2024, he bought 215,868 shares at an average price of $4.6167, totaling $996,59

Janus Henderson

CPI Aerostructures

Energy and Environmental... (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約